πŸ³οΈβ€βš§οΈ trans rights are human rights πŸ³οΈβ€βš§οΈ
Theme

Stirlingshire Broke Its Own Rules to Sell Banned Products to Everyday People.

FINRA AWC No. 2023077093401 • Regulatory Misconduct

Stirlingshire Broke Its Own Rules to Sell Banned Products to Everyday People

The Non-Financial Ledger: What a Spreadsheet Cannot Measure

Imagine you saved up enough money to finally open a brokerage account. You’re not a Wall Street trader. You don’t have a financial advisor on speed dial. You walked into, or logged into, a firm that is legally required to put your interests first. You trusted a professional with your savings.

Now imagine that the same firm had a written policy saying the products its brokers recommended to you were too dangerous for people like you. A policy that said: do not buy these for retail customers. Cancel all purchases. And then imagine that nobody at the firm ever actually enforced that policy. No alarm went off. No supervisor cancelled the trade. Nobody called to warn you. The trade just went through, and your money was on the line in a financial instrument designed to move violently and reset every single day.

That is exactly what happened at Stirlingshire Investments between November 2022 and April 2024. The firm’s written supervisory procedures prohibited its brokers from buying these leveraged and inverse ETFs in customer accounts. The prohibition was there in black and white. But not one alert, not one exception report, not one supervisory tool existed to enforce it. Three different brokers sold these products to more than 25 customers, and management either didn’t know or didn’t care.

Separately, 21 people were sold private, unregistered securities issued by Stirlingshire’s own parent company. These are the kinds of investments that regulators require extensive disclosure on precisely because ordinary investors cannot independently assess the risks. The disclosure documents that federal rules required to be filed before any investor ever received them were never filed with FINRA. Not for months. Not for over two years. They were finally submitted in December 2025, years after the sales were already done.

The people on the receiving end of these products didn’t know their broker’s firm had banned those products internally. They didn’t know the private placement materials they were handed had never been reviewed by a regulator. They trusted a licensed professional operating inside a regulated system. The system was supposed to catch this. It didn’t. And when it finally did, the firm paid $40,000 and moved on.

Timeline: From First Violation to Settlement June 2022 Stirlingshire joins FINRA as a member firm. Begins selling unregistered private placements same month. 5 months later November 2022 Brokers begin recommending banned NT-ETFs to retail customers. No supervisory controls active. 13 months of NT-ETF sales December 2023 Private placement sales to 21 investors end. Required FINRA filings: still not submitted. 4 more months of NT-ETF sales April 2024 NT-ETF misconduct period ends per AWC. Dec 2025 – Jan 2026 Late filings submitted. AWC signed Jan 22, 2026. Total misconduct window: June 2022 – April 2024 (approx. 22 months)

Legal Receipts: What the Documents Actually Say

The following quotes are taken verbatim from FINRA AWC No. 2023077093401. No paraphrase. No editorial spin. This is what regulators documented in the official settlement record.

  • This proves Stirlingshire was not ignorant of the risk. The firm had a written, internal prohibition on these exact products in retail accounts, which means leadership understood NT-ETFs were unsuitable for their customers.
  • This proves the prohibition was theater. No technical controls, no manual review process, and no reporting mechanism existed to make the prohibition real. The rule existed on paper and nowhere else.
  • This is the definition of a firm that chose compliance optics over compliance action.
  • FINRA first issued this warning in Regulatory Notice 09-31 in June 2009, and reinforced it in Regulatory Notice 12-03 in January 2012. By the time Stirlingshire was selling these products in 2022, this guidance was over a decade old.
  • The SEC independently cited both FINRA notices when it adopted Regulation Best Interest in 2019, which means the “retail investors shouldn’t hold these” standard had federal regulatory backing before Stirlingshire even became a FINRA member.
  • The rule requiring these filings, FINRA Rule 5122(b)(2), mandates submission at or before the first time a document is handed to any prospective investor. Stirlingshire handed documents to investors and filed nothing for over two years.
  • The securities involved were issued by Stirlingshire’s own parent company, meaning the firm had a direct financial interest in selling these products to the same customers it was supposed to be advising objectively.
  • The footnote in the AWC states filings were finally submitted in December 2025, which is after FINRA’s enforcement investigation was already underway. The timing strongly suggests the filings were prompted by regulatory pressure, not internal compliance.
“Three Stirlingshire registered representatives recommended that more than 25 retail customers purchase NT-ETFs, yet the firm failed to establish, maintain, and enforce written policies or procedures reasonably designed to achieve compliance with Reg BI’s Care Obligation.”
What Customers Were Told vs. What Was Actually Happening WHAT WAS CLAIMED THE REALITY The firm is a FINRA-registered broker required to act in your best interest. Brokers recommended products the firm’s own rulebook had banned for retail accounts. A supervisory system existed to protect you from unsuitable recommendations. No alerts, no exception reports, no supervisory tools existed whatsoever. The private placement memorandum you received was properly disclosed to regulators. Those documents were never filed with FINRA. Filed 2+ years late, under pressure. You are investing with a firm that has no conflict of interest. The unregistered securities were issued by Stirlingshire’s own parent company.

Societal Impact Mapping: Who Actually Pays for This

Public Health: Financial Harm Is Health Harm

The documented harm here is financial, but financial harm at the retail investor level has direct, well-documented consequences for physical and mental health, housing stability, and retirement security.

  • NT-ETFs are explicitly described in the regulatory record as products that can “differ significantly” from expected performance when held beyond a single trading day, especially in volatile markets. Retail investors who held these instruments overnight or longer were exposed to losses that could deviate wildly from what they were led to expect when they purchased.
  • Twenty-one investors were sold unregistered securities issued by the parent of the firm advising them. Private placement investments are illiquid by nature, meaning these investors may be unable to exit their positions if circumstances change. The absence of FINRA review meant regulators had no opportunity to flag any problematic disclosures before the money changed hands.
  • Retail investors who suffer unexpected losses frequently report elevated stress, sleep disruption, and anxiety. For older retail investors in particular, unexpected losses in brokerage accounts can directly affect retirement timelines, medication access, and housing decisions. The AWC does not document individual investor outcomes, but the products involved carry exactly the risk profile that produces these consequences.

Economic Inequality: The Rules Are Different When You’re Small

This case is a precise illustration of the two-tiered financial system that systematically disadvantages retail investors compared to institutional ones.

  • NT-ETFs are short-term trading instruments. Sophisticated institutional traders can use them effectively within a single session. Retail investors, who typically hold positions for days, weeks, or months, are structurally disadvantaged when these products are recommended to them without adequate disclosure of the daily-reset risk.
  • FINRA has required heightened supervisory procedures for complex products like NT-ETFs since 2012 and has tied compliance to the federal Regulation Best Interest standard since 2020. Stirlingshire was founded after both of these frameworks were in place. The firm had no excuse for the gap.
  • The $40,000 fine is the entire financial consequence imposed on Stirlingshire. No individual broker was fined. No individual supervisor was disciplined. No investor received restitution as part of this settlement. The cost of the misconduct is paid by the firm’s balance sheet, not by the people who made the recommendations or failed to stop them.
  • For the 25+ retail customers who received NT-ETF recommendations, the protection they were legally entitled to under Regulation Best Interest was never operationalized. The law existed. The obligation existed. The firm collected revenue from the trades anyway.
How NT-ETF Oversight Was Supposed to Work vs. What Stirlingshire Did REQUIRED BY LAW (REG BI + RULE 3110) WHAT STIRLINGSHIRE ACTUALLY DID Establish written supervisory procedures (WSPs) for complex product recommendations WSPs written β€” but stated NT-ETFs were prohibited. Policy existed; enforcement didn’t. Implement alerts and exception reports to flag any NT-ETF purchase attempts NO ALERTS. NO EXCEPTION REPORTS. STEP SKIPPED ENTIRELY. Supervisor reviews flagged trades; cancels unsuitable NT-ETF purchases NO REVIEWS CONDUCTED. TRADES WENT THROUGH UNCHALLENGED. Retail customers protected from unsuitable complex products 25+ retail customers received banned products for 17 months undetected DIVERGENCE

The “Cost of a Life” Metric: What $40,000 Actually Buys

  • The $40,000 fine covers both violations simultaneously: the 17-month NT-ETF supervisory failure affecting 25+ retail customers, and the 18-month failure to file private placement disclosures for products sold to 21 investors. No breakdown by violation is provided in the AWC.
  • By comparison, the annual salary of a mid-level compliance officer at a New York brokerage firm typically exceeds $100,000. The fine FINRA imposed is less than half of what it would cost to hire one compliance professional for one year. The fine does not cover the cost of the oversight that should have existed.
  • Stirlingshire waived its right to contest the fine, meaning the settlement amount was negotiated, not litigated. The AWC explicitly notes the firm “specifically and voluntarily waives any right to claim an inability to pay.” The $40,000 was not a ceiling imposed by financial hardship.
  • The firm also received a censure, which is a formal written reprimand, and agreed to an undertaking requiring a senior management certification of remediation within 90 days. The certification is internal paperwork submitted to FINRA. There is no public verification mechanism described in the AWC.
Entity Relationship Map: Who Sold What to Whom PARENT COMPANY [Name not disclosed in AWC] STIRLINGSHIRE INVESTMENTS CRD No. 310576 | FINRA Member owns / controls 3 REGISTERED REPS Recommended NT-ETFs (Nov 2022–Apr 2024) 1 REGISTERED REP Sold parent co. private placements 25+ RETAIL CUSTOMERS (NT-ETFs) 21 INVESTORS (PRIVATE PLACEMENT) Parent company securities sold to investors by firm’s own broker. Conflict of interest. Filings 2+ years late.

What Now? How to Hold Stirlingshire Accountable

Stirlingshire’s CEO and Founder Steven Woods signed this settlement on January 22, 2026. The AWC is now part of the firm’s permanent disciplinary record. The settlement is a starting point, not an ending.

Key Parties Named in the Settlement

  • Steven Woods, Founder and CEO of Stirlingshire Investments. Signed the AWC on behalf of the firm on January 22, 2026.
  • Kerry J. Land, Senior Counsel, FINRA Department of Enforcement. Accepted the AWC on January 13, 2026. Contact: Kerry.Land@finra.org.
  • William B. Mack, Shareholder, Greenberg Traurig LLP. Counsel for Stirlingshire in this proceeding.
  • The three registered representatives who made NT-ETF recommendations and the one registered representative who sold the private placements are not individually named in the AWC. FINRA enforcement against individual brokers, if any, would appear in separate proceedings.

Watchlist: Regulatory Bodies with Jurisdiction

  • FINRA (Financial Industry Regulatory Authority): The primary regulator here. Use FINRA BrokerCheck at www.finra.org/brokercheck to review Stirlingshire’s full disciplinary history, CRD No. 310576.
  • U.S. Securities and Exchange Commission (SEC): Regulates Regulation Best Interest compliance. File investor complaints at www.sec.gov/tcr.
  • FINRA Investor Complaint Center: If you were a Stirlingshire customer between June 2022 and April 2024, you can file a complaint at www.finra.org/investors/have-problem.
  • FINRA Arbitration: Retail investors who suffered financial losses may pursue individual arbitration claims through FINRA’s dispute resolution process, which is separate from this enforcement action.

Direct Action and Mutual Aid

  • If you or someone you know invested through Stirlingshire between June 2022 and April 2024, document your account statements, all communications from your broker, and all investment materials you received. This documentation is essential for any arbitration or complaint filing.
  • Share this investigation in investor advocacy communities on Reddit (r/investing, r/personalfinance), local financial literacy groups, and community social media. Retail investors protected each other long before regulators got involved.
  • Push your elected representatives to increase FINRA enforcement fine ceilings for supervisory failures. A $40,000 fine for a firm running a brokerage in New York is not a deterrent. It is a cost of doing business.
  • Support organizations that provide free financial literacy and legal aid to retail investors: the Public Investors Advocate Bar Association (PIABA) maintains a directory of attorneys who represent investors in FINRA arbitration, many on contingency.
  • Check your own brokerage account for NT-ETF positions. If you hold a leveraged or inverse ETF and you have not reviewed it since purchase, contact your broker in writing and ask for documentation of why that recommendation was made in your best interest.

The source document for this investigation is attached below.

Explore by category

01

Antitrust

Monopolies and anti-competition tactics used to crush rivals.

View Cases →
02

Product Safety Violations

When companies sell dangerous goods, consumers pay the price.

View Cases →
03

Environmental Violations

Pollution, ecological collapse, and unchecked greed.

View Cases →
04

Labor Exploitation

Wage theft, worker abuse, and unsafe conditions.

View Cases →
05

Data Breaches & Privacy

Misuse and mishandling of personal information.

View Cases →
06

Financial Fraud & Corruption

Lies, scams, and executive impunity that distort markets.

View Cases →
07

Intellectual Property

IP theft that punishes originality and rewards copying.

View Cases →
08

Misleading Marketing

False claims that waste money and bury critical safety info.

View Cases →
Aleeia
Aleeia

I'm Aleeia, the creator of this website.

I have 6+ years of experience as an independent researcher covering corporate misconduct, sourced from legal documents, regulatory filings, and professional legal databases.

My background includes a Supply Chain Management degree from Michigan State University's Eli Broad College of Business, and years working inside the industries I now cover.

Every post on this site was either written or personally reviewed and edited by me before publication.

Learn more about my research standards and editorial process by visiting my About page

Articles: 1806